These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction. Rosano GM; Vitale C; Volterrani M Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895 [TBL] [Abstract][Full Text] [Related]
4. [Heart rate: a risk factor or an epiphenomenon?]. Metra M; Zacà V; Lombardi C; Bugatti S; Dei Cas L G Ital Cardiol (Rome); 2010 Mar; 11(3):209-20. PubMed ID: 20550061 [TBL] [Abstract][Full Text] [Related]
5. Ivabradine: an intelligent drug for the treatment of ischemic heart disease. Riccioni G Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921 [TBL] [Abstract][Full Text] [Related]
7. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. DiFrancesco D; Camm JA Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560 [TBL] [Abstract][Full Text] [Related]
8. [Heart rate reduction due to selective specific inhibition of the If current opens new possibilities in treatment of basic cardiovascular diseases]. Chichkanov GG; Tsorin IB Eksp Klin Farmakol; 2013; 76(2):37-42. PubMed ID: 23631283 [TBL] [Abstract][Full Text] [Related]
10. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Vilaine JP Pharmacol Res; 2006 May; 53(5):424-34. PubMed ID: 16638639 [TBL] [Abstract][Full Text] [Related]
11. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease. Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608 [TBL] [Abstract][Full Text] [Related]
13. Heart rate reduction by pharmacological If current inhibition. Cargnoni A; Ceconi C; Stavroula G; Ferrari R Adv Cardiol; 2006; 43():31-44. PubMed ID: 16936470 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological control of heart rate]. Sirtori CR; Franceschini G Ann Ital Med Int; 1994 Oct; 9 Suppl():29S-35S. PubMed ID: 7857754 [TBL] [Abstract][Full Text] [Related]
15. Clinical perspectives of heart rate slowing for coronary event reduction and heart failure. Danchin N; Kadri Z Adv Cardiol; 2006; 43():45-53. PubMed ID: 16936471 [TBL] [Abstract][Full Text] [Related]
16. [Ivabradin (coraxan). One more new approach to fighting myocardial ischemia in patients with ischemic heart disease]. Eliseev OM Ter Arkh; 2006; 78(9):78-86. PubMed ID: 17076230 [No Abstract] [Full Text] [Related]
17. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966 [TBL] [Abstract][Full Text] [Related]
18. [Why it is necessary to reduce heart rate in the treatment of stable angina?]. Makolkin VI; Ziabrev FN Kardiologiia; 2006; 46(9):88-91. PubMed ID: 17047624 [TBL] [Abstract][Full Text] [Related]
19. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine. Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347 [TBL] [Abstract][Full Text] [Related]
20. Significance of reduction in heart rate in cardiovascular disease. Hjalmarson A Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II3-7. PubMed ID: 9853192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]